This document discusses meningitis and provides information on various types through multiple questions and case studies. It begins by stating that meningococcal meningitis has a case fatality rate of 80% without treatment, which can be reduced to less than 10% with early diagnosis and treatment. Vaccination is recommended for adolescents. Rifampicin or meningococcal vaccine is used for chemoprophylaxis of close contacts. The case studies provide details on patients presenting with meningitis caused by Neisseria meningitidis, group B streptococcus, and enterovirus.